This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Low-Risk Treatment for High-Risk Patients: A Journey From the Beginning of PCI
* Antithrombotic Pharmacotherapy During PCI: 25 Years of Evolving Therapy
* Progressively better outcomes with PCI
* Paradigm for Antithrombotic Drug Use/Development
* Major and Minor Bleeding in PCI Bleeding Increases Mortality and Events
* ACS Trials - Bleeding & Outcomes
* PRBC Transfusion Among NSTE ACS Patients: Cox model for 30-day Death
* Anticoagulant Therapy in the Cath Lab: Limitations of Unfractionated Heparin
* Heparin has a direct effect on platelets
* Paradigm for Antithrombotic Drug Bivalirudin Development in PCI
The moderator, Christopher Granger, MD, has indicated that he has no industry
relationships to disclose.
The guest, Magnus Ohman, MD, has indicated that he has no industry relationships to
disclose.
|
|